Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Mepolizumab reduces systemic corticosteroid-related toxicities and healthcare burden in patients with eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome: a retrospective database study.
Journal: Frontiers in allergy
Published: March 30, 2026
Real-world outcomes and corticosteroid sparing with mepolizumab for EGPA or HES.
Journal: The journal of allergy and clinical immunology. Global
Published: December 23, 2025
Mepolizumab exhibits quantifiable reduction in corticosteroid-related adverse effects in severe asthma.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: September 30, 2025
Mepolizumab reduces healthcare resource utilization in patients with chronic rhinosinusitis with nasal polyps: a linked EMR and claims-based pre-post study.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: July 25, 2025
Categorizing clinical response to mepolizumab for patients with chronic rhinosinusitis with nasal polyps: SYNAPSE trial.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: April 02, 2025
Primary care physicians play a crucial role in diagnosing and managing rare eosinophilic diseases: HES and EGPA.
Journal: Frontiers in medicine
Published: January 30, 2025
Burden of hypereosinophilic syndromes in the United States: Patients' perspective.
Journal: The journal of allergy and clinical immunology. Global
Published: November 26, 2024
Mepolizumab for the management of chronic rhinosinusitis with nasal polyps across the United States: A retrospective study.
Journal: The journal of allergy and clinical immunology. Global
Published: October 28, 2024
Long-Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: August 15, 2024
Real-world mepolizumab treatment in eosinophilic granulomatosis with polyangiitis reduces disease burden in the United States.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: August 13, 2024
Eosinophilic granulomatosis with polyangiitis: Patient profiles from a large US allergy practice.
Journal: The journal of allergy and clinical immunology. Global
Published: July 03, 2024
Quantifying corticosteroid burden in chronic rhinosinusitis with nasal polyps: A retrospective US database study.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: May 02, 2024
Last Updated: 09/26/2026